Using single-cell RNA sequencing of both immune and non-immune cells in the developing lung, Cohen et al. map candidate cell-cell interactions during alveolar macrophage development. This revealed potential cross-talk between epithelial cells, ILC2s, basophils, and the developing macrophages, which were validated both in vitro and in vivo.
Tissue-resident macrophages have unique tissue-specific transcriptomic profiles (Gosselin et al., 2014; Lavin et al., 2014) . However, how they acquire these profiles remains largely unknown. By comprehensively mapping developing lung cells using massively parallel singlecell RNA sequencing (MARS-seq), spatial localization, and examining the putative ligand-receptor interactions between the different lung cells, in this issue of Cell, Cohen et al. (2018) identify that crosstalk between alveolar type II epithelial cells, innate lymphocytes (ILC2s), and basophils modulates the development and function of alveolar macrophages.
To investigate alveolar macrophage development in the context of the whole organ, Cohen et al. perform MARS-seq on 50,770 lung cells (CD45 + and CD45 À ) across different time points of lung development. This analysis reveals transcriptional changes in multiple subsets of immune and non-immune cells. The authors identify three main clusters of developing macrophages. One cluster (Mac-I) predominates during embryogenesis and was defined as the yolk-sac-derived macs that initially seed the lung but are later largely replaced by infiltrating fetal liver monocytes (Hoeffel et al., 2015) . The Mac-II subset is mainly present around birth and resembles pre-alveolar macrophages expressing intermediate levels of Itgax and Siglec5 (Guilliams et al., 2013) . The Mac-III population slowly increases from late pregnancy on and corresponds with mature alveolar macrophages. The authors further define a trajectory using Slingshot between E16.5 monocytes and Mac-III, suggesting, consistent with previous reports, that Mac-II and subsequently Mac-III arise predominantly from fetal liver monocytes (Guilliams et al., 2013) . However, whether a second minor trajectory exists between Mac-I and Mac-III is not assessed. This is expected, as fate-mapping experiments indicate that a small fraction of alveolar macrophages are derived from yolk sac macrophages (Hoeffel et al., 2015) . Surprisingly, no interstitial macrophages were reported within the cells analyzed. These cells are proposed to derive from yolk sac macrophages early in development but then be replaced by circulating monocytes during the first weeks after birth (Tan and Krasnow, 2016) . Thus, it will be interesting to search for interstitial macrophages within the macrophages sequenced by Cohen et al. and see whether distinct trajectories leading to such cells can also be identified.
The authors further interrogate their sequencing data for putative ligandreceptor pairs between cell types to determine the interactions possibly governing the development and functions of lung cells. This analysis is complemented by spatial localization of the distinct cells allowing such ligand-receptor pairs to be practically evaluated. As a result of this, the authors identify cross-talk between alveolar type II epithelial cells, ILC2s, basophils and alveolar macrophages ( Figure 1) . Until now, alveolar type II epithelial cells were considered the main producers of the CSF2 (GM-CSF) driving alveolar macrophage development. Cohen et al. now identify ILC2s and baso-phils as additional sources of CSF2. In fact, they propose that IL33 and CSF2 produced by alveolar type II epithelial cells induce further production of CSF2 and IL13 by ILC2s and basophils, amplifying these signals. This model confirms a recent report describing the activation of ILC2s and basophils by IL33 from alveolar type II epithelial cells during the postnatal lung alveolarization phase (de Kleer et al., 2016) , which coincides with the period of alveolar macrophage development (Guilliams et al., 2013) . Interestingly, Cohen et al. propose that CSF2 and IL33 actively participate to the lungspecific imprinting of pulmonary basophils, inducing a number of genes absent from basophils in blood, including Il6, Il13, Il1b, and Csf2. The role of CSF2 and IL33 in this lung-specific basophil signature was validated using in vitro cultures and in vivo in mice deficient in Il1rl1. The concept that relatively short-lived cells such as basophils also undergo imprinting by their local environment highlights the need to study cells in vivo in the complex milieu in which they reside. Using Fcεr1mediated depletion of basophils in the postnatal stage and constitutive depletion of basophils using Mcpt8-CrexRosa-DTA mice, the authors observe a reduction in the alveolar macrophages in neonates and a reduction in alveolar macrophages in adults. In addition, the alveolar macrophages are impaired in their ability to phagocytose inactivated bacteria. The authors also delineate the role of IL33and CSF2-conditioned basophils in driving alveolar macrophage development in vitro, where bone-marrow-derived macrophages and immature lung macrophages could be skewed toward an alveolar macrophage-like phenotype if cocultured with in vitro generated basophils conditioned by IL33 and CSF2 and not with these cytokines alone or basophils cultivated in the absence of IL33 and CSF2.
While this study has shed light on the complex cellular interactions ongoing in the developing lung leading to alveolar macrophage development, some important questions remain to be answered. Primary among these is what are the precise factors produced by lung basophils that regulate development of these cells? Higher expression of receptors for these basophil-derived factors on fetal liver monocytes as compared to yolk-sac macrophages or bone-marrow monocytes may go some way to explaining the ontogeny of alveolar macrophages and why, when transferred together into an empty lung niche, fetal liver monocytes had a competitive advantage over the other progenitors in generating these cells (van de Laar et al., 2016) . In terms of function, while the constitutive depletion of basophils resulted in a decreased ability to phagocytose inactivated bacteria, the main steady-state function of alveolar macrophages is to clear excess surfactant from the lungs (van de Laar et al., 2016) . Thus, another key question is whether basophil-depleted mice develop alveolar proteinosis over time. It will also be interesting to assess if basophilmacrophage interactions regulate macrophage development and/or function in other tissues. This has been reported during Listeria monocytogenes infection, where IL4 from liver basophils is required for the repopulation of liver resident mac-rophages (Kupffer cells). Interestingly, in this instance it was IL33 produced by hepatocytes that induced basophil activation (Blé riot et al., 2015) . A last key question is whether this basophil-macrophage interaction is important throughout life or solely during alveolar macrophage development. Understanding this will be crucial for non-homeostatic conditions, especially those that drive a type 2 response, such as asthma. In this context, it was recently reported that monocytes differentiating into alveolar macrophages during herpes virus lung infections are distinct from homeostatic alveolar macrophages and protect against future asthma development (Machiels et al., 2017) . It could be that this virus infection temporarily disrupts the AT2-ILC2-basophil circuit that normally imprints their phenotype, yielding alveolar macrophages that have undergone a viral imprinting instead of the type 2 imprinting.
Taken together, this study illustrates that profiling the entire tissue by singlecell sequencing combined with spatial information and the identification of putative cell-cell interactions provides a great method for discovering novel tissue circuits regulating tissue-specific development and function of immune cells.
